Hansoh Pharmaceutical Group Company Limited 3KY.F Stock
Hansoh Pharmaceutical Group Company Limited Price Chart
Hansoh Pharmaceutical Group Company Limited 3KY.F Financial and Trading Overview
Contents
- Hansoh Pharmaceutical Group Company Limited Price Chart
- Hansoh Pharmaceutical Group Company Limited 3KY.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Hansoh Pharmaceutical Group Company Limited
- Q&A For Hansoh Pharmaceutical Group Company Limited Stock
| Hansoh Pharmaceutical Group Company Limited stock price | 1.9 EUR |
| Previous Close | 1.53 EUR |
| Open | 1.56 EUR |
| Bid | 1.5 EUR x N/A |
| Ask | 1.64 EUR x N/A |
| Day's Range | 1.56 - 1.56 EUR |
| 52 Week Range | 1.4 - 2.16 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 9.4B EUR |
| Beta (5Y Monthly) | 0.636427 |
| PE Ratio (TTM) | 26 |
| EPS (TTM) | 0.07 EUR |
| Forward Dividend & Yield | 0.02 (1.59%) |
| Ex-Dividend Date | June 5, 2023 |
| 1y Target Est | N/A |
3KY.F Valuation Measures
| Enterprise Value | -8195205632 EUR |
| Trailing P/E | 26 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.0023135 |
| Price/Book (mrq) | 0.40773654 |
| Enterprise Value/Revenue | -0.873 |
| Enterprise Value/EBITDA | -2.795 |
Trading Information
Hansoh Pharmaceutical Group Company Limited Stock Price History
| Beta (5Y Monthly) | 0.636427 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.16 EUR |
| 52 Week Low | 1.4 EUR |
| 50-Day Moving Average | 1.57 EUR |
| 200-Day Moving Average | 1.67 EUR |
3KY.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 5.93B |
| Float | 1.08B |
| Short Ratio | N/A |
| % Held by Insiders | 81.76% |
| % Held by Institutions | 8.44% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.088 |
| Trailing Annual Dividend Yield | 5.75% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2779 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 27.53% |
| Operating Margin (ttm) | 27.79% |
| Gross Margin | 90.72% |
| EBITDA Margin | 31.24% |
Management Effectiveness
| Return on Assets (ttm) | 5.70% |
| Return on Equity (ttm) | 12.10% |
Income Statement
| Revenue (ttm) | 9.38B EUR |
| Revenue Per Share (ttm) | 1.59 EUR |
| Quarterly Revenue Growth (yoy) | -10.59% |
| Gross Profit (ttm) | 8.51B EUR |
| EBITDA | 2.93B EUR |
| Net Income Avi to Common (ttm) | 2.58B EUR |
| Diluted EPS (ttm) | 0.06 |
| Quarterly Earnings Growth (yoy) | -9.59% |
Balance Sheet
| Total Cash (mrq) | 21.63B EUR |
| Total Cash Per Share (mrq) | 3.65 EUR |
| Total Debt (mrq) | 4.38B EUR |
| Total Debt/Equity (mrq) | 19.33 EUR |
| Current Ratio (mrq) | 9.861 |
| Book Value Per Share (mrq) | 3.826 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.74B EUR |
| Levered Free Cash Flow (ttm) | 1.45B EUR |
Profile of Hansoh Pharmaceutical Group Company Limited
| Country | Germany |
| State | N/A |
| City | Shanghai |
| Address | 287 Xiangke Road |
| ZIP | 201210 |
| Phone | 86 40 0828 5227 |
| Website | https://www.hspharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 10523 |
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including anti-tumor, anti-infectives, central nervous system diseases, metabolic diseases, and other therapeutic areas. Its principal products include Mailingda, Ameile, Hansoh Xinfu, Fulaimei, Hengmu, Xinwei, Tanneng, Ameining, Oulanning, Ailanning, Zetan, Ruibote, Fulaidi, Puruian, Fulairui, Pulaile, Zefei, Xinmei, Xintai, and Gainuo drugs, as well as XINYUE and Hengsen. The company serves pharmaceutical product distributors. It has a collaborations with NiKang Therapeutics to develop and commercialize NKT2152; TiumBio to develop and commercialize TU2670 for the treatment of endometriosis, uterine fibroids and other indications; Global Health Drug Discovery Institute to develop, manufacture, and commercialize the GDI-4405 series of anti-novel coronavirus; KiOmed Pharma SA to develop and commercialize KiOmedinevsOne for the treatment of osteoarthritis; and Biotheus Inc. to develop and commercialize PM1080. The company was founded in 1995 and is headquartered in Shanghai, the People's Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Q&A For Hansoh Pharmaceutical Group Company Limited Stock
What is a current 3KY.F stock price?
Hansoh Pharmaceutical Group Company Limited 3KY.F stock price today per share is 1.9 EUR.
How to purchase Hansoh Pharmaceutical Group Company Limited stock?
You can buy 3KY.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hansoh Pharmaceutical Group Company Limited?
The stock symbol or ticker of Hansoh Pharmaceutical Group Company Limited is 3KY.F.
Which industry does the Hansoh Pharmaceutical Group Company Limited company belong to?
The Hansoh Pharmaceutical Group Company Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hansoh Pharmaceutical Group Company Limited have in circulation?
The max supply of Hansoh Pharmaceutical Group Company Limited shares is 6.18B.
What is Hansoh Pharmaceutical Group Company Limited Price to Earnings Ratio (PE Ratio)?
Hansoh Pharmaceutical Group Company Limited PE Ratio is 27.14285700 now.
What was Hansoh Pharmaceutical Group Company Limited earnings per share over the trailing 12 months (TTM)?
Hansoh Pharmaceutical Group Company Limited EPS is 0.07 EUR over the trailing 12 months.
Which sector does the Hansoh Pharmaceutical Group Company Limited company belong to?
The Hansoh Pharmaceutical Group Company Limited sector is Healthcare.